# Naoxintong Capsule for Diabetic Nephropathy With Dampness Retention Pattern: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAcronymNXT-DKD

> **NCT07698223** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Chen Xiangmei** · enrollment: 410 (estimated)

## Conditions studied

- Diabetic Nephropathy

## Interventions

- **DRUG:** Naoxintong Capsule
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07698223
- **Lead sponsor:** Chen Xiangmei
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-03-01
- **Primary completion:** 2028-06-01
- **Final completion:** 2028-12-30
- **Target enrollment:** 410 (ESTIMATED)
- **Last updated:** 2026-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07698223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07698223, "Naoxintong Capsule for Diabetic Nephropathy With Dampness Retention Pattern: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAcronymNXT-DKD". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07698223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*